NCT01647191 is a NA clinical trial of intervention group in Hepatitis C, sponsored by Shanghai Mental Health Center.

Who is sponsoring NCT01647191?

NCT01647191 is sponsored by Shanghai Mental Health Center.

What drugs are being tested in NCT01647191?

Interventions in NCT01647191: intervention group, control group.

What condition does NCT01647191 study?

NCT01647191 studies Hepatitis C.

Is NCT01647191 still recruiting?

NCT01647191 is currently completed. Last updated 13 January 2020.

Last reviewed 2020-01-13 · How we verify

NCT01647191

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China

Completed NA Last updated 13 January 2020

What this trial tests

NA trial testing intervention group in Hepatitis C in 240 participants. Completed in 31 May 2015.

Timeline

1 July 2011

Primary endpoint
1 May 2015

31 May 2015

Quick facts

Lead sponsor	Shanghai Mental Health Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	240
Start date	1 July 2011
Primary completion	1 May 2015
Estimated completion	31 May 2015
Sites	2 locations across China

Drugs / interventions tested

intervention group — full drug profile →
control group — full drug profile →

Conditions studied

Hepatitis C — all drugs for Hepatitis C →

Sponsor

Shanghai Mental Health Center — full company profile →

Who can join

20 and older, any sex, with Hepatitis C. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed study will investigate the knowledge level, attitudes, and perceptions among staff of Methadone Maintenance Treatment (MMT) clinics and intravenous drug users (IDUs) who attending MMT clinics, which is the most reachable population for HCV/HIV intervention in China. This study will also explore the barriers that prevent IDUs from getting HCV/HIV intervention/prevention and medical care services. This study will help to understand and address this important problem in China and other Asian countries.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Hepatitis C infection, related services, and barriers to HCV treatment among drug users in methadone maintenance treatment (MMT) clinics in Shanghai, China.
Li ZB, Zhang L, Wang J, Huang LP, et al · · 2017 · cited 7× · PMID 29096647 · DOI 10.1186/s12954-017-0197-3
DOES IT WORK? -a randomized controlled trial to test the efficacy of HCV and HIV-related education on drug users in MMT, China.
Zhang JY, Li ZB, Zhang L, Wang J, et al · · 2019 · cited 4× · PMID 31488064 · DOI 10.1186/s12879-019-4421-5

Verify or expand the search:

Other trials of intervention group

Trials testing the same drug.

NCT06856395 — Effect of Using Educational Robots During Vaccination on Fear and Pain in Children · NA · not yet recruiting
NCT06842160 — Photoplethysmography (PPG) Algorithm with Smartwatch in Evaluation of Atrial Fibrillation Burden After Catheter Ablation · not yet recruiting
NCT07138430 — The Effect of Virtual Reality on Patient Outcome · NA · completed
NCT07082907 — Use Of Pet Therapy In Chıldren Receıvıng Nebulızer Treatment · completed
NCT06686940 — Photoplethysmography (PPG) Algorithm With Smartwatch in Evaluation of Atrial Fibrillation Burden · not yet recruiting

Other recruiting trials for Hepatitis C

Currently open trials in the same condition.

NCT06263829 — HCV Tappt Adherence Study · NA · recruiting
NCT06179498 — Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs · NA · recruiting
NCT06367465 — Feasibility and Acceptability of HCV Treatment in Pregnancy · recruiting
NCT05668780 — Buprenorphine Integration Research and Community Health · NA · active not recruiting
NCT05208697 — Tele-Harm Reduction · NA · active not recruiting

Other Shanghai Mental Health Center trials

Trials by the same sponsor.

NCT07480408 — Neural Mechanisms of the Sensorymotor Circuit in Sensory Phenomena in OCD · NA · not yet recruiting
NCT07479771 — tTIS Targeted of the Striatum as an Intervention for MUD Patients · NA · not yet recruiting
NCT07472673 — Transcranial Temporal Interference Stimulation Targeted of the Amygdala as an Intervention for Alcohol Use Disorder Pati · NA · not yet recruiting
NCT07484750 — Efficacy and Influencing Factors of Mindfulness-Based Exposure Group Therapy for OCD · NA · recruiting
NCT07311655 — Validation of the Accuracy of an AI-Based System for Diagnosing Anxiety Disorders · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01647191 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shanghai Mental Health Center
Last refreshed: 13 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01647191.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing